Back
Palisade Bio Vs. Cassava Sciences Industry Stock Comparison
Sell
26
PALI
Palisade Bio
Last Price:
2.57
Seasonality Move:
4.8%
Buy
63
SAVA
Cassava Sciences
Last Price:
27.08
Seasonality Move:
47.33%
Sell
26
Palisade Bio (PALI)
is a Sell
Is Palisade Bio a Buy, Sell or Hold?
- The current Palisade Bio [PALI] share price is $2.44. The Score for PALI is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- PALI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $32.18. The Score for SAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PALI Stock Price Chart
What is Palisade Bio's stock price today?
-
The Palisade Bio share price today is $2.44
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PALI is experiencing slight selling pressure.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $32.18
The current trend is moderately bullish and SAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
PALI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.26 | Sell |
| Relative Strength Index (14 RSI): | 37.27 | Sell |
| Chaikin Money Flow: | -33356 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.37 - 3.45) | Sell |
| Bollinger Bands (100): | (3 - 4.12) | Sell |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 64.8 | Buy |
| Chaikin Money Flow: | 2523870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.39 - 28.53) | Buy |
| Bollinger Bands (100): | (17.94 - 31.2) | Buy |
PALI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.42 | Buy |
| 20-day SMA: | 2.7 | Sell |
| 50-day SMA: | 3.24 | Sell |
| 200-day SMA: | 4.61 | Sell |
| 8-day EMA: | 2.47 | Sell |
| 20-day EMA: | 2.7 | Sell |
| 50-day EMA: | 3.11 | Sell |
| 200-day EMA: | 8.73 | Sell |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 26.62 | Buy |
| 50-day SMA: | 27.56 | Buy |
| 200-day SMA: | 22.93 | Buy |
| 8-day EMA: | 27.96 | Buy |
| 20-day EMA: | 27.22 | Buy |
| 50-day EMA: | 26.84 | Buy |
| 200-day EMA: | 24.22 | Buy |
Palisade Bio Earnings Growth & PALI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $16.15 per share, and an increase next year of $8.16 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Palisade Bio Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||